Pathology Flashcards

1
Q

Cell adaptation

  • hypertrophy
  • hyperplasia
  • atrophy
  • metaplasia
  • dysplasia
A
  • increase in structural proteins and organelle which increases size of cell
  • controlled proliferation of stem cells -> increase in amnt of cells
  • decrease in tissue mass because decrease in size or number of cells
  • reprogramming of stem cells causing replacement of one cell type to another because it is better at adapting to certain stressor
  • disordered precancerous epi cell growth characterized by loss of uniformity of cell size and shape
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Injury

  • reversible: ATP, ribosomes, membrane, nuclear, function
  • irreversible: membrane, mito, lysosome, nuclear
A
  • decrease in ATP -> decrease Ca activity and Na/K pmp -> cellular swelling; ribosomal detachment -> decrease protein synthesis; plasma membrane changes; nuclear changes; rapid loss of function
  • breakdown of plasma membrane -> Ca into cell -> activates proteases; mito damage dysfunction -> loss of ETC -> low ATP; rupture of lysosomes -> autolysis; nuclear degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Apoptosis

  • intrinsic: what is it, regulated by, Function of apoptotic, Function of anti-apoptotic
  • extrinsic: 2 pathways
A
  • regulating factor is withdrawn from proliferating cell causing apoptosis; BCL2 family, BAX and BAK: form pores into mito membrane -> release of cyto C from inner mito membrane to cytoplasm -> activation of capases; BCL2: keep mito membrane impermeable
  • ligand binding receptor (Fas-FasL or TNF-alpha) or immune cell mediated (CD8+ or NK)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of Necrosis

  • coagulative: seen in, due to, histo
  • liquefactive
  • caseous
  • fat
  • fibrinoid
  • gangrenous
A
  • ischemia / infarct; injury that denatures proteins; preserved cell architecture but nuclei disappear
  • bacterial abcesses or brain infarcts; PMN release lysosomal enzymes that digest tissue; cellular debris and macro -> cystic spaces and cavitations
  • TB, systemic fungi; macro wall off infecting organism -> granular debris; fragmented cells and debris surrounded by lymphocytes
  • enzymatic: acute pancreatitis, non-enzymatic: trauma; damaged pancreatic cells release lipase which breaks down trigly and FFA binds to CA -> causing chalk white appearance of fat; outline of dead fat cell w/o peripheral nuclei
  • immune vascular reaction; immune complex deposition and or plasma protein leakage from damaged vessel; vessel walls are thick and pink
  • distal extremity and GI tract after chronic ischemia; Dry: ischemia, wet: super-infection; coagulative or liquefactive on top of coagulative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ischemia

  • what is it
  • mechanism
A
  • inadequate blood supply to meet demand

- decrease arterial perfusion, decreased venous drainage, shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Type of infarct

  • red
  • white
A
  • occurs in venous occlusions and tissues w/ multiple blood supplies and with re-perfusion
  • occurs in solid organ with single blood supply
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Free radical injury

  • function
  • caused by
A
  • damage cell membrane by lipid peroxidation
  • radiation, meds, redox reactions, NO
  • scavenging enzymes, spontaneous decay, anti-oxidant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type of calcification

  • dystrophic: cell type, extent, etiology, serum Ca levels, associated conditions
  • metastatic: cell type, extent, etiology, serum Ca levels, associated conditions
A
  • in diseased tissue; localized; secondary to injury or necrosis; normal; TB, chronic abcess, fat necrosis, infarct
  • in normal tissue; widespread; secondary to hyper Ca; abnormal; in interstitum of kidney, lung, GI mucosa,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lipofuscin

  • what is it
  • cause
  • found in
A
  • yellow-brown wear and tear pigment associated w/ normal aging
  • oxidation and polymerization og autophagocytosed organellar membranes
  • heart, colon, liver, kidney, eye of elederly on autopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Amyloidosis

  • what is it/ pathogenesis
  • visualized w/
  • location
A
  • abnormal aggregation of proteins into beta pleated linear sheets -> insoluble fibrils -> cell damage and apoptosis
  • congo-red stain
  • glomerular mesangial areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Systemic amyloidosis

  • primary: fibril protein, seen in
  • secondary
  • dialysis
A
  • AL protein, seen in plasma cell disorders
  • serum amyloid A, seen in chronic inflamm conditions
  • B2 microglobulin, seen in pts with ESRD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Localized amyloidosis

  • Alzheimers: protein, from
  • Type II DM: protein, cause
  • Medullary thyroid CA: protein
  • Isolated atrial amyloidosis: protein, pathogenesis, risk
  • systemic senile amyloidosis: protein, location
A
  • Beta amyloid protein; cleaved from amyloid precursor protein
  • Islet amyloid polypeptide; caused by deposition of amylin in pancreatic islet cells
  • calcitonin
  • ANP, common in normal aging but puts at risk for a fib
  • transthyretin, seen predominantly in cardiac ventricles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hereditary amyloidosis

  • familial amyloid cardiomyopathy: protein, location, causes
  • familial amyloid polyneuropathy: protein
A
  • mutated transthyretin, ventricular endocardium -> restrictive cardiomyopathy
  • mutated transthyretin -> caused by tranthyretin gene mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inflammation

  • what is it
  • signs
  • acute phase
  • fever
A
  • response to eliminate cause of cell injury, remove necrotic cells and initiate tissue repair
  • erythema / heat (histamine/ prostaglandin/ bradykinin causing increase in vasodilation), tumor / swelling (leukotrienes, hitamine, serotonin causeeing endothelial disruption allowing for leakage of proteins and increasing interstial oncotic pressure), pain (bradykinin, PGE2, histamine causing sensitization of nerve endings), loss of function
  • fever, leukocytosis, increase in plasma acute phase protein produced by liver
  • pyrogens cause macro to release IL-1 and TNF -> increase COX -> in pervacsular cells in hypothal -> increase PGE2 -> increase set point
  • elevation of WBC count and type of cell depends on inciting agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute phase reactants

  • ferritin
  • fibrinogen
  • serum amyloid A
  • hepcidin
  • CRP
  • albumin
  • transferrin
A
  • upreg, binds and sequesters iron to inhibit microbial iron scavenging
  • upreg, coag factor, promotes endo repain, correlates with ESR
  • upreg, prolonged leads to amyloidosis
  • upreg, decrease iron absorption and release
  • upreg, opsonin
  • down reg, conserves AA
  • down reg, internalized by macrophages to sequester iron
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Erythrocyte sedimentation rate

- what is it

A
  • RBC normally able to remain separated by neg charge but with inflammation fibrinogen will coat RBC and decrese negative charge -> increase in RBC aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Exudate vs Transudate

  • exudate: cell, protein, caused by
  • transudate
  • light criteria
A
  • cellular (cloudy), high protein, lymph obstruction/ inflammation/ infection/ malignancy
  • hypocellular (clear), low protein, increase in hydrostatic pressure or decrease in oncotic pressure
  • pleural fluid is exudative if more than 1 of following criteria is met: has fluid/serum protein ration > 0.5, fluid/serum LDH ration > .6, pleural fluid LDH > 2/3 of upper limit of normal serum LDH
18
Q

Acute inflammation

  • what is it
  • characterized by
  • stimuli
  • mediators
  • vascular component
  • cellular component
  • outcomes
A
  • transient and early response to injury or infection
  • PMNs in tissue and edema
  • infection, trauma, necrosis, foreign bodies
  • TLR, arachadonic acid metabolites, PMN, eosinophil
  • vasodilation and increase in endothelial permeability
  • extravasion of leukocytes from post-cap venules and accumulation in location of injury
  • resolution and healing, abcess, scarring
19
Q

Leukocyte extravasion

  • margination and rolling: endo cells express, leukocytes express
  • tight binding: endo cells express, leukocytes express
  • diapedesis: what is it, endo cells express, leukocytes express
  • migration: what is it, endo cells express, leukocytes express
A
  • endo: E-selectin, P-selecting, GlyCAM1; Leuko: Sialyl lewis and L-selectin; leukocyte adhesion deficiency type 2 bs of decrease in sialyl lewis
  • endo: ICAM and VCAM; Leukocyte: CD11/12 and VLA4; defective in leukoocyte adhesion deificiency type 1
  • WBC travel between endo cell and exits blood vessel; PECAM-1 (both endo and leuko)
  • WBC travels in interstitium to site of injury or infection guided by chemotactic signal; endo: C5a, IL8
20
Q

Wound healing tissue mediators

  • FGF
  • TGF beta
  • VEGF
  • PDGF
  • Metalloproteinases
  • EGF
A
  • stimulates angiogenesis
  • angiogenesis and fibrosis
  • stimulate angiogenesis
  • secreted by platelets, induces vascular remodeling and smooth muscle cell migration, stimulates fibroblast growth for collagen synthesis
  • tissue remodeling
  • stimulates cell growth via tyrosine kinase
21
Q

Phase of wound healing

  • inflammatory
  • proliferative
  • remodeling
A
  • immediate to 3 days after wound; pleatelets, PMN, macro; clot formation, increase vessel permeability and PMN migration into tissue, macro clear debris 2 days later
  • 3 days to weeks after wound; fibroblasts, myofibrblasts, endothelial cells, keratinocytes, macro; deposition of granulation tissue and type III collagen, angiogenesis, epi cell proliferation, dissolution of clot and wound contraction
  • 1 week to 6 month; fibroblasts; type III colagen replaced by type I collagen to increase tensile strength of tissue, collagenases, zinc deficiency
22
Q

Phase of wound healing

  • inflammatory: time frame, cells involved, characteristics
  • proliferative: time frame, cells involved, characteristics
  • remodeling: time frame, cells involved, characteristics
A
  • immediate to 3 days after wound; pleatelets, PMN, macro; clot formation, increase vessel permeability and PMN migration into tissue, macro clear debris 2 days later
  • 3 days to weeks after wound; fibroblasts, myofibrblasts, endothelial cells, keratinocytes, macro; deposition of granulation tissue and type III collagen, angiogenesis, epi cell proliferation, dissolution of clot and wound contraction
  • 1 week to 6 month; fibroblasts; type III colagen replaced by type I collagen to increase tensile strength of tissue, collagenases, zinc deficiency
23
Q

Granulomatous inflammation

  • what is it
  • caused by
  • used for
  • histo
  • types
  • mechanism
  • anti TNF
A
  • pattern of chronic inflammation
  • by persistent T-cell response to certain infections
  • wall off a resistant stimulus w/o completely eradicating or degrading it
  • activated macrophage w/ abundant pink cytoplasm surrounded by lymphocytes lymphocytes and giant cells
  • caseating w/ central necrosis or non caseating w/o necrosis
  • APC present antigens to CD4 helper T cells and secrete IL-2 -> differentiate into Th1 cells -> secrete INF gamma -> macrophages activated -> macrophage increase cytokine secretion -> formation of giant cells
  • cause sequestering granulomas to break down -> disseminated disease
24
Q

Scar formation

  • what?
  • hypertrophic
  • keloid
A
  • occurs when repair cannot be accomplished by cell regeneration, non-regenerated cells replaced by CT
  • increased type III collagen, collagen is parallel, scar confined to to borders of original wound, infrequent recurrence and no predispostion
  • very high type I and III collagen, disorganized collagen organization, extends beyond border of original would with claw like projections typically on earlobes, face, UE, frequently recur, increase incidence in ethnic groups w/ darker skin
25
Neoplasia - what is it - components - dysplasia - carcinoma in situ - invasive carcinoma - mets
- uncontrolled, monoclonal proliferation of cells, can be malignant or benign - parenchyma (neoplastic cells) and supporting stroma (blood vessels, CT) - loss of uniformity in cell size and shape, loss of tissue orientation, nuclear changes - irreversible severe dysplasia that involves the entire thickness of epi but the basement membrane is intact - cells have invaded the basement membrane using collagenases and hydrolases, cell-cell contacts lost bu inactivation of E-cadherin - spread to distant organs via lymphatics or blood
26
Tumor nomenclature - carcinoma - sarcoma - benign - malignant - hamartoma - choriostoma
- epthelial origin - mesenchymal origin - well differentiated and wll demarcated, low mitotic activity, no mets, no necrosis - poor diferentiation, erratic growth, local invasion, mets, decreased apoptosis - disorganized growth of tissue in native location - normal tissue in foreign location
27
Cell type and types of CA - Epi: benign, malignant - blood cells: malignant - blood vessels: benign, malignant - SM: benign, malignant - Striated muscle: benign, malignant - CT: benign, malignant - Bone: benign, malignant - Fat: benign, malignant - Melanocyte: benign, malignant
- adenoma, papilloma; adenocarcinoma, papillary carcinoma - leukemia, lymphoma - hemangioma; angiosarcoma - leiomyoma; leiomyosarcoma - rhabdomyoma; rhabdomyosarcoma - fibroma; fibrosarcoma - osteoma; osteosarcoma - lipoma; liposarcoma - nevus; melanoma
28
Tumor grade vs Stage - grade - stage
- degree of cellular differentiation (how much it looks like tissue of origin) on histo - degree of localization/ spread based on site and size of primary location, spread to regional LN, presence of mets; determines survival
29
Immune evasion in CA - what happens - escape mechanisms
- immune cells can recognize and attack tumor cells - decreased MHC class I expression -> cytotoxic T cells unable to recognize tumor cells, secrete immunosuppressive factors, up-reg immune chekpoint mutations
30
Common Mets - sarcoma - carcinoma - four carcinoma route hemato
- hematogenously - lymph - follicular thyroid, choriocarcinoma, renal cell, and heptaocellular
31
Oncogenic Microbes - EBV - HBV, HCV - HHV-8 - HPV - H pylori - HTLV-1 - Liver fluke - Schistosoma
- Burkitt lymphoma - Heptaocellular carcinoma - Kaposi sarcoma - Cervical and penile/anal carcinoma, head and neck CA - gastric adenocarcinoma and MALT lymphoma - adult t-cell leukemia - cholangiocarcinoma - squamous cell bladder CA
32
Serum tumor marker - alk phos - alpha fetoprotein - hCG - CA-15/ CA 27-29 - CA 19-9 - CA 125 - Calcitonin - CEA - chromogranin - LDH - Neuron specific enolase - PSA
- mets to bone or liver, pagets dx, seminoma - hepatocellular carcinoma, mixed germ cell tumor, neural tube defects - hydatidiform mole and choriocarcinoma - breast CA - pancreatic adenocarcinoma - ovarian carcinoma - medullary thyroid carcinoma - colorectal and pancreatic carcinoma - neuroendocrine tumor - testicular germ cell tumors, ovarian dysgerminoma - neuroendocrine tumor - prostate CA
33
IHC stains - chromogranin - cytokeratin - desmin - GFAP - neurofilament - s-100 - TRAP
- neuroendocrine cells -> small cell carcinoma of lung - epithelial cells - muscle - neuroglia -> astrocytoma, glioblastoma - neurons - neural crest cells - hair cell leukemia
34
P- glycoprotein - in - for
- in adrenocortical carcinoma | - used to pump out toxins including chemo agents
35
Psammoma bodies - histo - which cancers
- laminated, concentric spherules w/ dystrophic calcification - papillary carcinoma of thyroid, somatostatinoma, meningioma, mesothelioma, ovarian serous papillary cystadenocarcinoma, prolactinma
36
Cachexia - what is it - caused by
- weight loss, muscle atrophy, and fatigue that occurs w/ chronic dx - TNF alpha, IFN gamma, IL-1 and 6
37
Paraneoplastic Syndrome MS and cutaneous - dermatomyositis: description/ mechanism; most common tumor - acanthosis nigricans - sign of leser-trelat - hypertrophic osteoathropathy
- progressive proximal muscle waekness, gottron papules, heliotrope rash - hyperpigmented velvety plaques in axilla and neck - sudden onset of mult seborrheic keratoses - abnrml proliferation of skin and bone at distal extremities
38
Paraneoplastic Syndrome endocrine - hypercalcemia: description/ mechanism; most common tumor - cushing syndrome - hyponatremia
- PTHrP; suamous cell carcinoma of lung, head, and neck - high ACTH, small cell lung CA - High ADH, small cell lung CA
39
Paraneoplastic Syndrome hematologic - polycythemia: description/ mechanism; most common tumor - pure red cell plasia - good syndrome - trosseau syndrome - nonbacterial throbmotic endocarditis
- increased erythropoietin; pheochromocytoma, renal cell carcinoma - anemia w/ low reticulocytes; thymoma - hypogammaglobulinemia; thymoma - migratory superficial thrombophlebitis; adenocarcinoma - deposition of sterile platelet thrombi on heart valves; adenocarcinoma
40
Paraneoplastic Syndrome Neuromuscular - anti NMDA receptor encephalitis: description/ mechanism; most common tumor - opsoclonus-myoclonus ataxia syndrome - paraneoplastic cerebellar degeneration - paraneoplastic encephalomyelitis - lamber-eatn myasthenic syndrome - myasthenia gravis
- psych disturbances, memory deficits, seizures; ovarian teratoma - dancing eyes and feet; neuroblastoma and small cell lung - antibodies against purkinje cells; small cell, gycenologic and breast CA - antibodies against Hu antigen in neuron; small cell lung CA - antibodies against pre-synaptic channels at NMJ; small cell lung CA - antibodies against postsynaptic Ach receptors at NMJ; thymoma